Therefore, the use of a suitable preclinical model prone to atherosclerosis development, such as LDL receptor- or ApoE-deficient mice [86], will be required to evaluate the beneficial effects of Totum-070 on atherosclerosis. This evidence concerns the gene APOE and atherosclerosis.